Vesiculobullous Lesions of the Oral Cavity

SA Alramadhan, MN Islam - Oral and …, 2023 - oralmaxsurgery.theclinics.com
Vesiculobullous lesions involving the oral cavity may represent the oral manifestations of
dermatologic diseases, particularly those that are immunemediated. Several vesiculobullous …

[HTML][HTML] Anti-Idiotypic mRNA Vaccine to Treat Autoimmune Disorders

SK Niazi - Vaccines, 2023 - mdpi.com
The 80+ existing autoimmune disorders (ADs) affect billions with little prevention or
treatment options, except for temporary symptomatic management, leading to enormous …

[HTML][HTML] Oleogel-S10 in dystrophic epidermolysis bullosa: a case series evaluating the impact on wound burden over two years

M Torres Pradilla, E Álvarez, M Novoa, I Lozano… - Advances in …, 2024 - Springer
Epidermolysis bullosa (EB) is a group of rare, difficult-to-treat, inherited multisystem
diseases affecting epithelial integrity. Impaired wound healing is central and can lead to …

[HTML][HTML] Retrospective analysis of autoimmune bullous diseases in Middle Franconia

L Sollfrank, V Schönfelder, M Sticherling - Frontiers in Immunology, 2023 - frontiersin.org
Introduction Autoimmune bullous diseases (AIBDs) are a group of rare cutaneous disorders
affecting cornified skin and mucous membranes. They are characterized by tense or flaccid …

Epidermolysis bullosa: new insights for the future

F Martora, G Fabbrocini, T Battista… - Clinical and …, 2022 - academic.oup.com
Dear Editor, We read with great interest the article by Bageta et al. 1 recently published in
Clinical and Experimental Dermatology. The authors described three cases of children with …

[HTML][HTML] Intravenous Immunoglobulin for Autoimmune Bullous Diseases: A Case Series from a Central European Referral Center

MM Spałek, M Bowszyc-Dmochowska, M Dmochowski - Medicina, 2023 - mdpi.com
Background and Objectives: Autoimmune bullous diseases (AIBDs) may be treated with
intravenous immunoglobulin (IVIG) infusions. This study aimed to evaluate the benefits and …

Clinical and immunopathological characteristics of autoimmune blistering skin diseases.

A Gunaric, D Simic, B Marinovic - Acta Dermatovenerologica Alpina …, 2023 - go.gale.com
Autoimmune blistering skin diseases (AlBDs) encompass several heterogeneous conditions
clinically characterized by blisters and erosions on the skin and mucous membranes and …

[HTML][HTML] Epidermolysis bullosa acquisita

A Xiao, NC Sathe, A Tsuchiya - StatPearls [Internet], 2023 - ncbi.nlm.nih.gov
Objectives: Identify the clinical manifestations and symptoms of epidermolysis bullosa
acquisita to facilitate early diagnosis. Implement evidence-based treatment strategies and …

[HTML][HTML] IgM-mediated epidermolysis bullosa acquisita

S Harrison, V Mayes, C Brimhall, R King - JAAD Case Reports, 2024 - Elsevier
Epidermolysis bullosa acquisita (EBA) is a rarely reported autoimmune subepidermal
bullous disease that is typically identified as skin fragility with the formation of tense vesicles …

[HTML][HTML] Epidermolysis bullosa acquisita following skin graft in donor and graft sites: A case report

J Xia, AJ Tan, GP Nielsen, RK Foreman, M Hoang… - Burns Open, 2023 - Elsevier
Epidermolysis bullosa acquisita is a rare mucocutaneous autoimmune blistering disorder
which usually presents in adulthood. The disease is mediated by antibodies against type VII …